Pricing Guide

Mounjaro Cost

Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Mounjaro Cost is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Mounjaro Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.

Key Fact

Weight Method's compounded tirzepatide program is $329/month, all-inclusive, with no insurance required. Weight Method does not dispense brand-name Mounjaro®. Mounjaro is FDA-approved for type 2 diabetes; compounded tirzepatide is not FDA-approved.

Source: Weight Method pricing, February 2026

How much does treatment cost per month?

Mounjaro's pricing follows Eli Lilly's specialty pharmaceutical model. Actual pharmacy prices vary by location and dose. Cash-pay discount tools like GoodRx may bring prices down somewhat, but availability is inconsistent. Insurance coverage for Mounjaro is strongest when prescribed for type 2 diabetes, where it may sit on a preferred brand tier with a lower copay. For weight loss, coverage is rare since Mounjaro's FDA label is diabetes-specific. The weight-management-labeled tirzepatide product is Zepbound®. Weight Method's $329/month compounded tirzepatide pricing is a flat all-inclusive monthly fee — the same from the starting 2.5mg through the maximum 15mg. Compounded tirzepatide is not FDA-approved.

How can you save on treatment?

Weight Method's compounded tirzepatide program is a flat $329/month all-inclusive fee that does not change with insurance decisions or formulary updates. Brand-name Mounjaro purchased cash-pay at a retail pharmacy is set by Eli Lilly and is a much larger monthly outlay for patients without coverage. The decision between them is not purely financial — Mounjaro is FDA-approved (for type 2 diabetes), while compounded tirzepatide is not. Published clinical-trial outcomes describe the FDA-approved brand-name tirzepatide products and should not be assumed to apply to compounded tirzepatide, which is not FDA-evaluated. Weight Method's compounded tirzepatide program bundles medication, provider consultations, dosing management, and shipping into one predictable monthly cost, eliminating the incidental expenses (specialist visits, lab work, pharmacy dispensing fees) of the conventional pathway.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Brand-name Mounjaro purchased cash-pay at a retail pharmacy is set by the manufacturer and is a significant out-of-pocket cost without coverage. Weight Method's compounded tirzepatide program is $329/month, all-inclusive, with no insurance required. Mounjaro is FDA-approved for type 2 diabetes; compounded tirzepatide is not FDA-approved.

Unlikely. Mounjaro® is FDA-approved only for type 2 diabetes, so most insurers will not cover it for weight loss. The weight-loss-labeled tirzepatide product is Zepbound®, but coverage for that is also limited.

Both are FDA-approved Eli Lilly products containing tirzepatide. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. The active ingredient and mechanism are identical; the indications and doses differ.

At retail pharmacies, Mounjaro is generally priced similarly across doses, though some pharmacies vary by location. Weight Method's $329/month compounded tirzepatide rate is flat across all doses from 2.5mg through 15mg.

No. Mounjaro® is the FDA-approved brand-name medication manufactured by Eli Lilly. Compounded tirzepatide is prepared by a U.S.-licensed 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality.

Get GLP-1 at the Best Price

We offer the most affordable GLP-1 treatments. Starting at $199/month.

See Pricing

Free consultation. No commitment.

Other Cost Guides

Mounjaro Cost by State